Skip to content

Walking program for elderly women with high blood pressure

Walking program for elderly hypertensive women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-3h5394
Enrollment
Unknown
Registered
2018-11-06
Start date
2018-12-05
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

Walking group: 20 elderly hypertensive participants will perform 30 to 50 minutes of walking in an outdoor environment at self-selected intensity and pace three times a week for eight weeks. Control g
Behavioural
E02.760.169.063.500.387

Sponsors

Hospital Universitario Onofre Lopes
Lead Sponsor
Universidade Federal do Rio Grande do Norte
Collaborator

Eligibility

Sex/Gender
Female
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age between 60 and 75 years; women; body mass index lower than 35 kg/m2; physically inactive; previous diagnosis of hypertension; absence of any other cardiometabolic disorder or disease; no severe musculoskeletal problem that limits walking practice; signed consent form; medical clearing after physical exercise test

Exclusion criteria

Exclusion criteria: Change in medication during the study period; withdrawal the consent form

Design outcomes

Secondary

MeasureTime frame
Reduction of the 24-hour ambulatory diastolic blood pressure levels after 8 weeks of walking, verified through ambulatory blood pressure monitoring, shown as a statistically significant variation (p<0.05) between the pre- and postintervention measurements;Improvement of cardiorespiratory fitness after 8 weeks of walking, verified through walking test 6 minutes, shown as a statistically significant variation (p <0.05) between the pre- and postintervention measurements

Primary

MeasureTime frame
Reduction of the 24-hour ambulatory systolic blood pressure levels after 8 weeks of walking, verified through ambulatory blood pressure monitoring, shown as a decrease of at least 5 mmHg between the pre- and post-intervention measurements

Countries

Brazil

Contacts

Public ContactJúlio Sócrates Silva

Universidade Federal do Rio Grande do Norte - UFRN

juliosocratess@gmail.com+55(84)32153451

Outcome results

None listed

Source: REBEC (via WHO ICTRP)